TAVI Market by Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation), and by End-user (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers)- Global Opportunity Analysis and Industry Forecast 2022-2030
Industry: Healthcare | Publish Date: 20-Jan-2022 | No of Pages: 215 | No. of Tables: 118 | No. of Figures: 88 | Format: PDF | Report Code : N/A
Speak to Our Analyst
Market Definition:
The TAVI Market was valued at USD 4.89 billion in 2021 and is predicted to reach USD 16.32 billion by 2030, registering a CAGR of 14.6% from 2022 to 2030. Transcatheter aortic valve implantation (TAVI) also known as transcatheter aortic valve replacement (TAVR)is an open-heart surgery that is performed to treat aortic stenosis.
An aorta is a large artery that carries blood from the heart to the rest of the body. TAVI is a minimally invasive method that is designed to replace a diseased aortic valve with an artificial valve through blood vessels, without removing the old, damaged valve. This method is used for the renewal of dysfunctional and damaged heart valves, especially for high-risk category patients that are unfit to undergo an operation or surgical valve replacement (SAVR)procedure.
Market Dynamics and Trends
The demand for TAVI is increasing due to the rise in the prevalence of aortic stenosis coupled with developments in healthcare infrastructure for TAVR across various healthcare institutes including Minneapolis Heart Institute and Asian Heart Institute.
Also, factors such as advancements in transcatheter aortic valves that include improved pre-procedural assessment with dedicated protocols of computed tomography (CT) image acquisition and reconstruction as well as rise in demand for various TAVI procedures to treat cardiovascular issues are expected to drive the TAVI market growth.
Moreover, TAVI has become a well-known standard of care for patients unable to undergo an operation. The improved awareness among patients & physicians about the benefits of transcatheter aortic is anticipated to drive the growth of the TAVR Device industry, during the forecast time frame.
For instance, in September 2020, The Heart Valve Centre, a unit of HeartTeam India presented the TAVR World Tour to educate the masses about modern cardiac treatments. It is the first cardiovascular health awareness campaign comprising 20 cardiac specialist teams from 20 different cities across the world live on one global platform (JioMeet).
The lack of skilled healthcare professionals and the high cost of treatment are factors that are expected to restrain the TAVI market growth, during the forecast period. On the other hand, a lower risk of infection as a result of technological advancements such as new-generation TAVI devices is expected to create new opportunities for the market in future.
Market Segmentations and Scope of the Study
The global TAVI market is segmented based on procedure, end-user, and geography. Based on procedure, the market is divided into transfemoral implantation, transapical implantation, and transaortic implantation. Based on end-user, the market is classified into hospitals, cardiac catheterization laboratories, and ambulatory surgical centers. The geographic breakdown and analysis of each of the preceding divisions involve regions comprising North America, Europe, Asia-Pacific, and RoW.
Geographical Analysis
North America held the lion’s share of the global TAVI market in 2021 and is expected to continue dominating the market during the forecast period. This is attributed to factors such as the presence of developed healthcare infrastructure along with high R&D expenditure for the development of these devices.
Also, the rise in the prevalence of coronary artery diseases, hypertension, or heart failure that needs surgical aortic treatment is supplementing the market growth. Moreover, the demand for TAVI is increasing due to the surging prevalence in the U.S., which consists of a large geriatric population, that is most vulnerable to valvular aortic stenosis. For instance, in 2020, according to the Americal College of Cardiology, since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more than 276,000 patients have undergone a TAVR procedure in the U.S.
Asia-Pacific is expected to exhibit a steady rise in the global TAVI market during the forecast period, due to factors such as increasing incidences of cardiovascular disorders, and rising accessibility to healthcare facilities in this region. Also, growing medical tourism in countries such as Japan, Thailand, and Singapore, including procedures of TAVI in the region is expected to fuel the market in this region.
Moreover, the presence of key companies such as Meril Life Sciences Pvt. Ltd and Venus Medtech, Inc., that adopt various strategies to expand their business in this region is propelling the growth of the TAVI industry. For instance, in July 2020, Venus Medtech, announced a collaboration with Pi-Cardia Ltd. to introduce Pi-Cardia’s Leaflex™ technology to China. This was aimed at enabling a lower-cost non-implant-based solution for patients with calcified aortic valves.
Competitive Landscape
The TAVI market comprises key players such as Abbott, JC Medical Inc., Meril Life Sciences Pvt. Ltd., HLT, Inc. (Bracco), Boston Scientific Corporation, JenaValve Technology Inc., Edwards Lifesciences Corporation, Medtronic, Venus Medtech (Hangzhou) Inc, and NVT AG(Blue Sail Medical) among others. These players are actively indulging in R&D initiatives, product & technology innovations, and industrial collaborations to enhance their products and increase their sales growth and geographical reach.
For instance, in August 2021, Medtronic plc., announced the approval of the U.S. Food and Drug Administration (FDA) for its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system. It is designed specially to enhance ease of use and provide greater precision and control throughout the procedure.
Additionally, in September 2021, Abbott announced the U.S FDA approval of the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system in order to treat people suffering from severe aortic stenosis, symptomatic that are at extreme risk for open-heart surgery through minimally invasive therapies.
KEY BENEFITS
-
The TAVI market report provides a quantitative analysis of the market estimations through 2022-2030 that assists in identifying the prevailing market opportunities to capitalize on.
-
The study comprises a deep-dive analysis of the market, including the current and future trends for depicting the prevalent investment pockets in the industry.
-
The information related to key drivers, restraints, and opportunities and their impact on the TAVI market is provided in the report.
-
The competitive analysis of the market players along with their revenue, in the global TAVI market, is provided in the report.
-
The SWOT analysis and Porter’s Five Forces model are elaborated in the study.
-
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
TAVI MARKET KEY SEGMENTS
By Procedure
-
Transfemoral Implantation
-
Transapical Implantation
-
Transaortic Implantation
By End User
-
Hospitals
-
Cardiac Catheterization Laboratories
-
Ambulatory Surgical Centers
By Geography
-
North America
-
U.S
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Spain
-
Italy
-
Netherlands
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Russia
-
Rest of Europe
-
-
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Thailand
-
Singapore
-
Rest of Asia-Pacific
-
-
RoW
-
Latin America
-
Middle East
-
Africa
-
KEY PLAYERS
-
Abbott
-
JC Medical Inc.
-
Meril Life Sciences Pvt. Ltd.
-
HLT, Inc.(Bracco)
-
Boston Scientific Corporation
-
JenaValve Technology, Inc.
-
Edwards Lifesciences Corporation.
-
Medtronic
-
Venus Medtech (Hangzhou) Inc.
-
NVT AG (Blue Sail Medical)
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Qualitative Approach
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
Our Specialized Toolbox for Industry-Specific Market Research
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
Information Procurement
The stage entails acquiring market data or relevant information through various sources and methodologies.
Market Research Approach
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
Porters Five Forces Analysis
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
SWOT Analysis
We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.
Forecasting
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
Frequently Asked Questions
Download Free Sample
Related Report
Related Blogs
Technological Advancements Shaping The Minimally Invasive Surgical Systems Market
Introduction The landscape of medical interventions is un...
Revolutionizing Kidney Health: Latest Trends and Advancements in Dialysis Technology
Introduction Dialysis, a crucial medical procedure, is ca...
Transforming Healthcare With Patient Monitoring Innovations
Introduction Patient monitoring refers to the continuous or periodic observat...
